The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.

Download and Print: Download Printer-friendly PDF Download data

Table 6.28

Cancer of the Colon and Rectum (Invasive)

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2017
By Race/Ethnicity, Sex and Years Since Diagnosis

Race/Ethnicity Sex Years Since Diagnosis Completee
0 to 5 >5 to 10 >10 to 15 >15 to 20 >20 to 25 <=25b >25d
All Races Both Sexes 454,973 315,517 232,226 156,277 86,705 1,245,698 102,389 1,348,087
Males 235,008 159,606 115,821 77,858 42,445 630,738 42,841 673,580
Females 219,965 155,912 116,405 78,419 44,259 614,960 59,547 674,507
White Both Sexes 367,700 258,195 193,427 132,779 73,607 1,025,709 87,047 1,112,756
Males 191,130 131,805 98,283 66,954 36,302 524,475 36,781 561,256
Females 176,570 126,390 95,144 65,825 37,305 501,234 50,266 551,500
Black Both Sexes 55,497 35,839 25,364 15,527 8,694 140,921 9,178 150,100
Males 26,931 16,527 10,839 6,872 3,947 65,117 3,646 68,763
Females 28,567 19,312 14,524 8,654 4,747 75,805 5,532 81,336
Asian/
Pacific
Islander		 Both Sexes 22,099 14,831 9,904 5,916 3,390 56,140 + +
Males 11,784 7,575 4,848 2,904 1,655 28,766 + +
Females 10,315 7,256 5,055 3,012 1,735 27,374 + +
Hispanic Both Sexes 41,755 25,151 15,479 8,853 4,483 95,721 + +
Males 21,730 13,169 7,820 4,512 2,259 49,490 + +
Females 20,025 11,982 7,659 4,341 2,225 46,231 + +

Estimated prevalence percent a on January 1, 2017, of the SEER population diagnosed in the previous 25 years
By Age at Prevalence, Race/Ethnicity and Sex

Race/Ethnicity Sex Age Specific (Crude) Age-Adjustedc
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races Both Sexes 0.3843 0.0001 0.0028 0.0085 0.0348 0.1296 0.4123 0.8410 1.6146 2.8343 0.3225
Males 0.3952 - 0.0023 0.0072 0.0343 0.1324 0.4471 0.9597 1.8925 3.2339 0.3663
Females 0.3738 0.0001 0.0033 0.0099 0.0352 0.1268 0.3791 0.7336 1.3822 2.5855 0.2878
White Both Sexes 0.4053 0.0001 0.0033 0.0095 0.0358 0.1295 0.3974 0.8025 1.5836 2.8550 0.3169
Males 0.4182 - 0.0027 0.0080 0.0353 0.1323 0.4322 0.9196 1.8658 3.2375 0.3603
Females 0.3927 0.0002 0.0038 0.0111 0.0364 0.1267 0.3633 0.6939 1.3423 2.6125 0.2818
Black Both Sexes 0.3094 - 0.0010 0.0044 0.0318 0.1292 0.4560 1.0428 1.8389 2.7245 0.3522
Males 0.2979 - 0.0008 0.0035 0.0331 0.1251 0.4732 1.1558 2.0556 3.2678 0.3938
Females 0.3200 - 0.0013 0.0053 0.0307 0.1327 0.4411 0.9526 1.6874 2.4532 0.3257
Asian/
Pacific
Islander		 Both Sexes 0.2692 - 0.0013 0.0043 0.0223 0.1071 0.4007 0.8267 1.4672 2.3469 0.2900
Males 0.2877 - 0.0015 0.0044 0.0200 0.1194 0.4606 0.9748 1.7651 2.7030 0.3391
Females 0.2521 - 0.0011 0.0041 0.0244 0.0962 0.3488 0.7075 1.2287 2.1147 0.2517
Hispanic Both Sexes 0.1647 0.0001 0.0023 0.0057 0.0265 0.0968 0.3293 0.7252 1.3399 2.0475 0.2583
Males 0.1685 - 0.0015 0.0046 0.0248 0.0974 0.3475 0.8308 1.6303 2.5483 0.3032
Females 0.1607 0.0001 0.0031 0.0068 0.0283 0.0962 0.3113 0.6314 1.1161 1.7367 0.2251

Footnotes:

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the Alaska Native Registry) and 1/1/2017 US population estimates based on the average of 2016 and 2017 population estimates from the US Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years.

b Maximum limited-duration prevalence is 25 years for 1992-2017 data.

c Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

d Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

e Complete prevalence is obtained by summing <=25 and >25.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.